Method for producing pharmaceutical drug particles of small particle size
Pharmaceutical drug particles of small particle size are produced by combining a solvent-non-solvent precipitate with an in-situ spray drying process. A pharmaceutical drug is dispersed in a water-miscible solvent, in particular ethanol, and heated in an infeed line under pressure to above the boiling point of the solvent until the drug dissolves. This solution collides as a fine liquid jet with a fine water jet in a gas-permeated microreactor, and the fine mist so arising vaporises rapidly. The organic solvent vaporizes first, then the water. The water may contain surface modifiers.
1. Method for producing pharmaceutical drug particles of small particle size, comprising the following steps:
Dissolving pharmaceutical drug particles in a water-miscible solvent
Pumping the thus-prepared dispersion under raised pressure through a dispersion conveyor line at the end of which a nozzle that functions as a pressure regulator is located
Dissolving the drug particles by heating the dispersion conveyor line to a temperature above the boiling point of the solvent at normal pressure to create a drug solution,
Passage of the drug solution through the nozzle of a precipitation/spray-drying reactor
Collision of the liquid jet of drug solution with a liquid jet formed by another nozzle of the precipitation/spray-drying reactor, the latter jet consisting of water or an aqueous solution
Maintenance of a gaseous atmosphere at the collision point of the liquid jets by supplying gas to blow the precipitation zone free, or by at least partial vaporisation of solvent and water in the collision zone as a result of the pressure drop following the passage of the jets through the respective nozzles, or, where a free-jet reactor is used, by gravity-based removal of the dispersion mist
Extremely rapid mixing due to mixing taking place in the form of impinging jets in a gaseous atmosphere, with a mixing time of less than 100 ms, preferably less than one ms
Formation of nanoparticulate nuclei by very fast diffusion-controlled solvent/non-solvent precipitation at the collision point and the plate-like mixing zone of the liquid jets in a gaseous atmosphere.
2. Method according to claim 1 , wherein the dispersion conveyor line has an additional, pump-fed input for pure solvent, the temperature of the solvent being higher than the solvent's boiling point at normal pressure and higher than the temperature of the dispersion conveyor line, thus causing rapid solution of the remaining still-undissolved dispersed particles in the dispersion being conveyed and reducing the time during which the drug is under thermal stress.
3. Method according to claim 1 , wherein the latter jet consists of an aqueous solution containing biocompatible constituents that modify the surface of the ultrafine particles formed during precipitation.